Coherus Biosciences | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
AbbVie USD 4.81B 1.54B 2024-12
Acadia Pharmaceuticals USD 27.78M 133.31M 2025-03
ALKERMES USD 443.75M 333.52M 2024-12
Alnylam Pharmaceuticals USD -41596000 152.36M 2025-03
Amarin USD -13630000 197K 2025-03
Amgen USD 3.38B 111M 2024-12
Baxter International USD -289000000 594M 2024-12
Biogen USD 572.2M 118.5M 2024-12
BioMarin Pharmaceutical USD 169.64M 35.2M 2024-12
Bristol-Myers Squibb USD 2.97B 1.29B 2025-03
Eli Lilly USD 3.46B 2.08B 2025-03
Fujifilm JPY 103.45B 6.69B 2025-03
Gilead Sciences USD 2.96B 112M 2024-12
Ironwood Pharmaceuticals USD 17.37M 4.14M 2024-09
Merck USD 5.22B 114M 2024-12
Myriad Genetics USD 6.2M 2.1M 2024-12
Pacira USD 8.71M 16.82M 2025-03
Perrigo USD 8.3M 143M 2025-03
Pfizer USD 4.44B 2.36B 2024-12
PTC Therapeutics USD -94699000 3.29M 2024-12
Regeneron Pharmaceuticals USD 905M 53.1M 2025-03
Sarepta Therapeutics USD -383518000 555.26M 2025-03
Teva Pharmaceutical Industries USD 294M 605M 2025-03
Vertex Pharmaceuticals USD 1.32B 109.7M 2024-12
Xencor USD -48265000 4.36M 2025-03
Zoetis USD 773M 144M 2024-12



Coherus Biosciences Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Jul 2025.